Critically important patients access to crucial drugs not restricted once we leave EU – Ashworth

Jonathan Ashworth MP, Labour’s Shadow Health Secretary, responding to the Health Select Committee’s first evidence session into Brexit, said:

“The Prime Minister must urgently heed this dire warning at the Health Select Committee. It is critically important that patients’ access to crucial drugs is not restricted in any way once we leave the European Union.

“Earlier today at the Britain Against Cancer Conference, I warned of the significant unresolved questions the Government must answer regarding our future access to radioactive isotopes, as well as our future relationship with EU clinical trials regulation.

“Theresa May must also immediately safeguard the future of EU workers here in Britain and stop treating them as bargaining chips in her reckless Brexit negotiations. Failure to do so risks exacerbating the already dire crisis in our health and care system.”